Press "Enter" to skip to content

Sensex, Nifty Snap Two-Day Winning Streak Dragged By Metals, Banking Stocks – BloombergQuint

Shares of Torrent Pharmaceuticals Ltd. shed over 4.4% in intraday trade, to Rs 2,813.85 apiece, lower than any close since June 9, after the company reported Q2 net income below average analyst estimate.

Torrent Pharma Q2FY22 (Consolidated, QoQ)

  • Revenue up 0.14% at Rs 2,137 crore Vs Rs 2,134 crore (BBG estimate: Rs 2,172.4 crore)

  • Net profit down 4% at Rs 316 crore Vs Rs 330 crore (BBG estimate: Rs 328.3 crore profit)

  • Ebitda down 3% at Rs 660 crore Vs Rs 677 crore (BBG estimate: Rs 683.3 crore)

  • Margins at 30.9% Vs 31.7% (BBG estimate: 31.5%)

  • EPS at Rs 18.63 per share Vs Rs 19.53 (BBG estimate: Rs 19.6)

Trading volume was triple the 20-day average volume for this time of the day.

Torrent Pharma trades at 36 times its estimated earnings per share for the coming year.

Analysts have 16 ‘buy’, seven ‘hold’ and six ‘sell’ recommendations on the stock.